Forbes contributors provide expert analyses. Teva's layoffs reflect challenges in the pharmaceutical sector, where generics struggle against branded drugs due to market structures favoring profits. The need to reform incentives, curb PBM influence, and prioritize value and competition is crucial for sustainable drug costs and innovation.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing